C-reactive protein levels and prevalence of chronic infections in subjects with hypoalphalipoproteinemia
Introduction
Low concentrations of plasma high-density lipoprotein cholesterol (HDL-C) (hypoalphalipoproteinemia) are associated with an increased risk of cardiovascular disease. Data from the Framingham studies suggest that for each 1-mg/dL decrease in HDL-C, the risk of coronary heart disease (CHD) increases by 2% to 4% [1]. Isolated hypoalphalipoproteinemia, low levels of HDL-C and normal low-density lipoprotein cholesterol (LDL-C) concentrations, is the most common lipid abnormality found in young survivors of a myocardial infarction [2], and its prevalence is very high in patients with angiographically documented CHD [3]. The pathophysiological mechanisms involved in this association are not completely understood, but interactions between oxidant activity, reverse cholesterol transport, and, more recently, inflammatory responses have been suggested.
Levels of C-reactive protein (CRP), a sensitive marker of inflammation [4], [5], have been shown to be increased in subjects with primary hypoalphalipoproteinemia, a condition characterized by very low levels of HDL-C. Inflammation [6] and high levels of CRP [7], [8] have been shown to be related to the development of atherosclerosis and cardiovascular events. As such, the hypothesis that follows could be that the connection between hypoalphalipoproteinemia and cardiovascular disease may be mediated, at least in part, by inflammation.
Because most cases of hypoalphalipoproteinemia result from a mixture of secondary causes (eg, hypertriglyceridemia, obesity, sedentary lifestyle, smoking habit, prescribed drugs/medications) or are due to an inherited monogenic or polygenic pattern, we sought to clarify the relationship between low HDL-C and inflammation by measuring the CRP concentrations in consecutive patients with nonselected hypoalphalipoproteinemia who attend our outpatient lipid clinic and by comparing them with the levels in control subjects with normal HDL-C concentrations. Case patients and control subjects were carefully matched for the presence of cardiovascular disease and associated risk factors. Because some existing infections are able to produce low-grade inflammation [9] and influence lipoprotein levels [10], we investigated whether the relationship between CRP and HDL-C could be mediated by concomitant chronic infections.
Section snippets
Patients
This is a case-control study conducted in patients with dyslipidemia who attend the Atherosclerosis Clinic of the Carlos III Hospital (Madrid). All patients with hypoalphalipoproteinemia, defined as HDL-C below 40 mg/dL in 2 determinations at least 1 week apart, were recruited. Individuals with acute infection or inflammation, any chronic renal, hepatic, or inflammatory disease, diabetes, cancer, alcohol consumption of more than 30 g/d and those undergoing treatment with corticosteroids or
Results
A total of 172 subjects, 86 case patients (84% of whom were male) and 86 control subjects, was included in the study. Clinical characteristics of the participants are presented in Table 1. Both groups were well balanced with respect to gender, age, body mass index (BMI), and smoking habit. No differences in LDL-C were found between the 2 groups. As expected, HDL-C concentration was lower and triglyceride concentrations were higher in case patients relative to control subjects. The
Discussion
A number of primary and secondary prevention studies [12], [13] have demonstrated an independent association between CRP and the incidence of CHD. Before incorporating CRP measurements into the CHD risk estimation, it is important to identify the factors that can influence its concentration in the circulation. In the present study, we found that nonselected individuals with hypoalphalipoproteinemia have an increased level of CRP, which, traditionally, has been seen as a marker of systemic
Acknowledgments
This study has been supported by a grant from the Fundación para el Fomento y Desarrollo de la Investigación Clínica and a grant from Fondo de Investigaciones Sanitarias 98/0201.
We thank Luisi Elez for excellent technical assistance.
References (31)
- et al.
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study
Am. J. Med.
(1977) - et al.
Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias
Metabolism
(2003) - et al.
C-reactive protein, inflammation, and coronary risk
Med. Clin. North Am.
(2000) - et al.
Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease
J. Am. Coll. Cardiol.
(1998) - et al.
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)
J. Am. Coll. Cardiol.
(2001) - et al.
C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol
Metabolism
(2003) - et al.
Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors
Atherosclerosis
(2003) - et al.
Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes
Blood
(2001) - et al.
Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines
Am. J. Cardiol.
(2003) - et al.
Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels
J. Am. Coll. Cardiol.
(1999)
Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
J. Am. Coll. Cardiol.
Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease
Atherosclerosis
Familial lipoprotein disorders in patients with premature coronary artery disease
Circulation
Long-term predictors of subsequent cardiovascular events with coronary artery disease and ‘desirable’ levels of plasma total cholesterol
Circulation
Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: a proinflammatory condition?
Circulation
Cited by (15)
Association between inflammation, lipid and hemostatic factors in patients with stable angina
2007, Thrombosis ResearchElevated C-reactive protein levels in individuals with low high-density lipoprotein cholesterol levels [1] (multiple letters)
2005, Metabolism: Clinical and ExperimentalCurrent Helicobacter pylori Infection Is Associated with Early Liver Injury: A Cross-Sectional Study in the General Population
2023, American Journal of Tropical Medicine and HygieneHelicobacter pylori infection and fatty liver
2020, Eksperimental'naya i Klinicheskaya Gastroenterologiya/Experimental and Clinical GastroenterologyLipidome Abnormalities and Cardiovascular Disease Risk in HIV Infection
2019, Current HIV/AIDS Reports